Angélique B van 't Wout

Author PubWeight™ 31.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 2003 4.56
2 A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol 2006 2.05
3 Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 2003 1.75
4 HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis 2008 1.70
5 Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models. Mol Biol Evol 2010 1.16
6 Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing. PLoS Pathog 2011 1.15
7 Evidence for limited genetic compartmentalization of HIV-1 between lung and blood. PLoS One 2009 1.09
8 Clinical significance of HIV-1 coreceptor usage. J Transl Med 2011 1.07
9 Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays. Antimicrob Agents Chemother 2009 1.04
10 Reconstructing the dynamics of HIV evolution within hosts from serial deep sequence data. PLoS Comput Biol 2012 1.00
11 Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection. Virology 2010 0.98
12 Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics. Retrovirology 2012 0.96
13 Low incidence of HIV-1 superinfection even after episodes of unsafe sexual behavior of homosexual men in the Amsterdam Cohort Studies on HIV Infection and AIDS. J Infect Dis 2011 0.92
14 Evaluation of pre-screening methods for the identification of HIV-1 superinfection. J Virol Methods 2010 0.88
15 Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course. PLoS One 2011 0.88
16 Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages. PLoS One 2011 0.87
17 Absence of HIV-1 superinfection 1 year after infection between 1985 and 1997 coincides with a reduction in sexual risk behavior in the seroincident Amsterdam cohort of homosexual men. Clin Infect Dis 2010 0.86
18 HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression. AIDS 2012 0.86
19 Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Clin Infect Dis 2013 0.85
20 Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates. Transfusion 2007 0.83
21 The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair. Virology 2011 0.81
22 Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia. PLoS One 2012 0.80
23 Polymorphism in HIV-1 dependency factor PDE8A affects mRNA level and HIV-1 replication in primary macrophages. Virology 2011 0.80
24 Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control. AIDS 2011 0.79
25 T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates. Virology 2006 0.79
26 HIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism. PLoS One 2012 0.79
27 Gene expression profiling of HIV-1 infection using cDNA microarrays. Methods Mol Biol 2005 0.78
28 The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression. PLoS One 2013 0.75